Charles River to buy MPI Research for $800m
Charles River Laboratories International says it is en route to ‘double its size in five years’ with the acquisition of non-clinical CRO MPI Research.
Charles River Laboratories International says it is en route to ‘double its size in five years’ with the acquisition of non-clinical CRO MPI Research.
Bayer has received a US FDA warning letter at its finished pharmaceutical facility in Leverkusen, Germany.
Sun Pharma says there was no direct loss of production at its Gujarat active pharmaceutical ingredient (API) facility following a fire last week.
CTTI has completed more than 25 projects on issues affecting clinical trials over the past decade, since which time the industry has changed greatly, says executive director.
Arbutus Biopharma Corporation is cutting operations but says it remains committed to developing its messenger RNA drug delivery technology.